Page last updated: 2024-08-22

fluorine and ER-Negative PR-Negative HER2-Negative Breast Cancer

fluorine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dai, J; Gao, Y; Guo, S; Hu, W; Shi, D; Yu, Y; Zhang, J; Zheng, Q	1

Other Studies

1 other study(ies) available for fluorine and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
The Fluoro-Thiazolylhydrazone Compound TSC-3C Inhibits Triple Negative Breast Cancer (TNBC) Cell Line Activity by Promoting Apoptosis, Regulating the MAPK Pathway and Inducing Mitochondrial Dysfunction. International journal of molecular sciences, 2020, Feb-04, Volume: 21, Issue:3 Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fluorine; Heterocyclic Compounds; Humans; Hydrazones; Mitochondrial Diseases; Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Triple Negative Breast Neoplasms	2020

Article

Year

The Fluoro-Thiazolylhydrazone Compound TSC-3C Inhibits Triple Negative Breast Cancer (TNBC) Cell Line Activity by Promoting Apoptosis, Regulating the MAPK Pathway and Inducing Mitochondrial Dysfunction.

International journal of molecular sciences, 2020, Feb-04, Volume: 21, Issue:3

Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fluorine; Heterocyclic Compounds; Humans; Hydrazones; Mitochondrial Diseases; Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Triple Negative Breast Neoplasms

2020